Patents by Inventor Aileen KELLY

Aileen KELLY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway
    Patent number: 11820781
    Abstract: This disclosure relates to compounds useful for degrading BTK via a ubiquitin proteolytic pathway. The description also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
    Type: Grant
    Filed: December 3, 2020
    Date of Patent: November 21, 2023
    Assignee: Nurix Therapeutics, Inc.
    Inventors: Aileen Kelly, Arthur T. Sands
  • BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK VIA UBIQUITIN PROTEOSOME PATHWAY
    Publication number: 20230227471
    Abstract: This disclosure relates to compounds useful for degrading BTK via a ubiquitin proteolytic pathway. The description also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
    Type: Application
    Filed: March 10, 2023
    Publication date: July 20, 2023
    Inventors: Aileen KELLY, Arthur T. SANDS
  • BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK VIA UBIQUITIN PROTEOSOME PATHWAY
    Publication number: 20210198280
    Abstract: This disclosure relates to compounds useful for degrading BTK via a ubiquitin proteolytic pathway. The description also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
    Type: Application
    Filed: December 3, 2020
    Publication date: July 1, 2021
    Inventors: Aileen KELLY, Arthur T. SANDS